Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Translated into:
Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Introduction to BURSURE-S Iron Sucrose Injection 20 mg:
BURSURE-S Iron Sucrose Injection 20 mg is an advanced intravenous iron formulation aimed at effectively treating iron deficiency anemia, especially in patients with chronic kidney disease. Produced with stringent quality control, BURSURE-S ensures safe and efficient iron delivery to those in need.
Uses of BURSURE-S Iron Sucrose Injection 20 mg:
Effectively treats iron deficiency anemia in CKD patients
Suitable for patients undergoing hemodialysis or peritoneal dialysis
Ideal for individuals who cannot tolerate or respond to oral iron supplements
Benefits of BURSURE-S Iron Sucrose Injection 20 mg:
Rapid and efficient replenishment of iron stores
Significant improvement in hemoglobin levels
Low risk of adverse effects
Suitable for patients with gastrointestinal absorption issues or intolerance to oral iron
Mechanism of Action of BURSURE-S Iron Sucrose Injection 20 mg:
BURSURE-S contains iron sucrose, a stable iron complex, which is administered intravenously. Once in the bloodstream, iron sucrose is absorbed by the reticuloendothelial system and gradually released for hemoglobin synthesis and ferritin incorporation. This controlled release mechanism ensures a steady and effective correction of iron deficiency, promoting better health outcomes for patients.